PL2135091T3 - Sposoby spektrometrii mas w analizie glikanów - Google Patents

Sposoby spektrometrii mas w analizie glikanów

Info

Publication number: PL2135091T3
Authority: PL; Poland
Prior art keywords: glycans; methods; evaluate; things; identification
Prior art date: 2007-04-16

Application number

PL08745856T

Other languages

English (en)

Inventor

Carlos J Bosques

Nathaniel J Washburn

Xiangping Zhu

Ian Christopher Parsons

Original Assignee

Momenta Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-16

Filing date

2008-04-15

Publication date

2011-11-30

2008-04-15 Application filed by Momenta Pharmaceuticals Inc filed Critical Momenta Pharmaceuticals Inc

2011-11-30 Publication of PL2135091T3 publication Critical patent/PL2135091T3/pl

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Physics & Mathematics (AREA)
Medicinal Chemistry (AREA)
Pathology (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Bioinformatics & Computational Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Tropical Medicine & Parasitology (AREA)
Spectroscopy & Molecular Physics (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

PL08745856T 2007-04-16 2008-04-15 Sposoby spektrometrii mas w analizie glikanów PL2135091T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US92367707P	2007-04-16	2007-04-16
PCT/US2008/060334 WO2008128221A1 (en)	2007-04-16	2008-04-15	Ms methods to evaluate glycans
EP08745856A EP2135091B1 (en)	2007-04-16	2008-04-15	Ms methods to evaluate glycans

Publications (1)

Publication Number	Publication Date
PL2135091T3 true PL2135091T3 (pl)	2011-11-30

Family

ID=39615678

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08745856T PL2135091T3 (pl)	2007-04-16	2008-04-15	Sposoby spektrometrii mas w analizie glikanów

Country Status (14)

Country	Link
US (1)	US8043863B2 (pl)
EP (1)	EP2135091B1 (pl)
JP (1)	JP5116837B2 (pl)
AT (1)	ATE512366T1 (pl)
AU (1)	AU2008240074B2 (pl)
CA (1)	CA2682750A1 (pl)
CY (1)	CY1111811T1 (pl)
DK (1)	DK2135091T3 (pl)
ES (1)	ES2367210T3 (pl)
HR (1)	HRP20110610T1 (pl)
PL (1)	PL2135091T3 (pl)
PT (1)	PT2135091E (pl)
SI (1)	SI2135091T1 (pl)
WO (1)	WO2008128221A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE512366T1 (de)	2007-04-16	2011-06-15	Momenta Pharmaceuticals Inc	Ms-verfahren zur evaluierung von glycanen
EP2702077A2 (en)	2011-04-27	2014-03-05	AbbVie Inc.	Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2013158273A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Methods to modulate c-terminal lysine variant distribution
WO2013158279A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Protein purification methods to reduce acidic species
US9067990B2 (en)	2013-03-14	2015-06-30	Abbvie, Inc.	Protein purification using displacement chromatography
EP4397768A3 (en)	2012-07-26	2024-12-18	Momenta Pharmaceuticals, Inc.	Glycoproteins with anti-inflammatory properties
US9512214B2 (en)	2012-09-02	2016-12-06	Abbvie, Inc.	Methods to control protein heterogeneity
CA2905010A1 (en)	2013-03-12	2014-09-18	Abbvie Inc.	Human antibodies that bind human tnf-alpha and methods of preparing the same
US8956830B2 (en)	2013-03-14	2015-02-17	Momenta Pharmaceuticals, Inc.	Methods of cell culture
WO2014151878A2 (en)	2013-03-14	2014-09-25	Abbvie Inc.	Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en)	2013-10-18	2015-04-28	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9217168B2 (en)	2013-03-14	2015-12-22	Momenta Pharmaceuticals, Inc.	Methods of cell culture
ES2802274T3 (es)	2013-05-02	2021-01-18	Momenta Pharmaceuticals Inc	Glicoproteínas sialiladas
US10464996B2 (en)	2013-05-13	2019-11-05	Momenta Pharmaceuticals, Inc.	Methods for the treatment of neurodegeneration
US9598667B2 (en)	2013-10-04	2017-03-21	Abbvie Inc.	Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US20160257754A1 (en)	2013-10-16	2016-09-08	Momenta Pharmaceuticals Inc.	Sialylated glycoproteins
US9085618B2 (en)	2013-10-18	2015-07-21	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same
US9181337B2 (en)	2013-10-18	2015-11-10	Abbvie, Inc.	Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en)	2013-11-15	2015-05-21	Abbvie, Inc.	Glycoengineered binding protein compositions
WO2017117218A1 (en)	2015-12-30	2017-07-06	Momenta Pharmaceuticals, Inc.	Methods related to biologics
EP3863673A4 (en)	2018-10-11	2023-01-11	Momenta Pharmaceuticals, Inc.	TREATMENT WITH HIGHLY SIALYLATED IGG COMPOSITIONS
MX2021008030A (es)	2018-12-31	2021-08-05	Momenta Pharmaceuticals Inc	Metodos para producir ustekinumab.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3383587B2 (ja) *	1998-07-07	2003-03-04	株式会社東芝	静止画像連続情報記録方法と光ディスクと光ディスクの情報再生装置と情報再生方法
WO2003078960A2 (en) *	2002-03-11	2003-09-25	Momenta Pharmaceuticals, Inc.	Analysis of sulfated polysaccharides
CA2510250A1 (en) *	2002-12-20	2004-08-12	Momenta Pharmaceuticals, Inc.	Glycan markers for diagnosing and monitoring disease
WO2005009039A2 (en) *	2003-07-03	2005-01-27	Waters Investments Limited	System and method for isotopic signature and mass analysis
US7138228B2 (en) *	2003-09-05	2006-11-21	Regents Of The University Of California	Protein O-sulfonation
WO2005111627A2 (en)	2004-04-15	2005-11-24	Massachusetts Institute Of Technology	Methods and products related to the improved analysis of carbohydrates
JP4614960B2 (ja) *	2004-08-04	2011-01-19	エーザイ・アール・アンド・ディー・マネジメント株式会社	同位体比によるペプチドを構成するアミノ酸配列の検定
JP2006047239A (ja) *	2004-08-09	2006-02-16	National Institute Of Advanced Industrial & Technology	硫酸化単糖の同定方法及び硫酸化単糖異性体混合物の分析方法
JP2009507212A (ja) *	2005-09-02	2009-02-19	オーストラリアンヌークリアサイエンスアンドテクノロジーオーガニゼイション	同位体比質量分析計および同位体比の決定方法
ATE512366T1 (de)	2007-04-16	2011-06-15	Momenta Pharmaceuticals Inc	Ms-verfahren zur evaluierung von glycanen

2008
- 2008-04-15 AT AT08745856T patent/ATE512366T1/de active
- 2008-04-15 HR HR20110610T patent/HRP20110610T1/hr unknown
- 2008-04-15 PL PL08745856T patent/PL2135091T3/pl unknown
- 2008-04-15 WO PCT/US2008/060334 patent/WO2008128221A1/en not_active Ceased
- 2008-04-15 JP JP2010504184A patent/JP5116837B2/ja active Active
- 2008-04-15 PT PT08745856T patent/PT2135091E/pt unknown
- 2008-04-15 DK DK08745856.8T patent/DK2135091T3/da active
- 2008-04-15 AU AU2008240074A patent/AU2008240074B2/en not_active Expired - Fee Related
- 2008-04-15 ES ES08745856T patent/ES2367210T3/es active Active
- 2008-04-15 SI SI200830367T patent/SI2135091T1/sl unknown
- 2008-04-15 EP EP08745856A patent/EP2135091B1/en active Active
- 2008-04-15 CA CA002682750A patent/CA2682750A1/en not_active Abandoned
- 2008-04-15 US US12/595,894 patent/US8043863B2/en active Active
2011
- 2011-09-08 CY CY20111100864T patent/CY1111811T1/el unknown

Also Published As

Publication number	Publication date
JP2010525327A (ja)	2010-07-22
AU2008240074B2 (en)	2013-02-21
US20100133430A1 (en)	2010-06-03
CA2682750A1 (en)	2008-10-23
SI2135091T1 (sl)	2011-10-28
DK2135091T3 (da)	2011-09-19
WO2008128221A1 (en)	2008-10-23
JP5116837B2 (ja)	2013-01-09
HRP20110610T1 (hr)	2011-10-31
ES2367210T3 (es)	2011-10-31
EP2135091A1 (en)	2009-12-23
EP2135091B1 (en)	2011-06-08
US8043863B2 (en)	2011-10-25
PT2135091E (pt)	2011-09-01
AU2008240074A1 (en)	2008-10-23
CY1111811T1 (el)	2015-10-07
ATE512366T1 (de)	2011-06-15

Publication	Publication Date	Title
PT2135091E (pt)	2011-09-01	Métodos de ms para avaliar glicanos
MX2010005682A (es)	2010-06-22	Anticuerpos bivalentes, biespecificos.
MX2010005888A (es)	2010-06-22	Anticuerpos bivalentes biespecificos.
MX2010006396A (es)	2010-07-05	Anticuerpos bivalentes, biespecificos.
UA100874C2 (en)	2013-02-11	Bivalent bispecific antibodies
MX340558B (es)	2016-07-14	Anticuerpos biespecificos que comprenden fragmento fv estabilizado con disulfuro.
PH12014501108A1 (en)	2014-08-04	Anti-il-36r antibodies
MX338711B (es)	2016-04-28	Pirrolobenzodiazepinas y conjugados de las mismas.
UY33703A (es)	2012-06-29	Anticuerpos anti-il-23
MY161909A (en)	2017-05-15	Anti-her3 antibodies and uses thereof
MX366303B (es)	2019-07-04	Pirrolobenzodiazepinas y conjugados de las mismas.
MX2011010012A (es)	2011-12-06	NUEVOS ANTICUERPOS ANTI-A5ß1 Y SUS USOS.
CL2012000590A1 (es)	2012-08-17	Proceso para preparar w-transaminasa (r)-selectiva.
MY162901A (en)	2017-07-31	Surface-treated calcium carbonate for binding and bioremediating hydrocarbon-containing compositions
MY155330A (en)	2015-09-30	Methods for salt production
SG145667A1 (en)	2008-09-29	Chronograph watch
ATE532814T1 (de)	2011-11-15	Neue ammonium-polyurethan- und/oder polycarbonat- verbindungen
MX2012010317A (es)	2012-12-17	ß-HIDROXIALQUILAMIDAS, METODO PARA SU PRODUCCION Y SU USO.
MX362457B (es)	2019-01-18	Antagonistas del receptor tipo toll 3.
AR058253A1 (es)	2008-01-30	Procedimiento para la preparacion de ferri-succinilcaseina
UA34276U (ru)	2008-08-11	7-β-ГИДРОКСИЭТИЛ-3-МЕТИЛ-8-N-ПИРРОЛИДИНОКСАНТИН, КОТОРЫЙ ПРОЯВЛЯЕТ ДИУРЕТИЧЕСКОЕ ДЕЙСТВИЕ
UA29068U (ru)	2008-01-10	Способ изготовления конструкционной смеси "ПЕНОРЕЗОЛ"
UA65321U (en)	2011-12-12	Binder
AU323946S (en)	2009-01-19	Tumbler
UA71312U (uk)	2012-07-10	N-β-ГІДРОКСІЕТИЛБЕНЗИЛАМОНІЮ 3,7-ДИМЕТИЛІМІДАЗО [1,2-f]КСАНТИНІЛ-8-ПРОПАНОАТ, ЯКИЙ ВИЯВЛЯЄ АНАЛЬГЕТИЧНУ ДІЮ